Christopher A. Wall, M.D.

Dr. Wall's research is primarily focused on pediatric mood disorders. Specifically, he has sponsored two separate Food and Drug Administration (FDA) Investigational Device Exemption (IDE) applications in the study of repetitive transcranial magnetic stimulation (rTMS) in adolescent depression.

He recently received the 2011 Klingenstein Third Generation Foundation Fellowship in Pediatric Depression and has numerous other research and teaching awards.

Dr. Wall also has recently published and presented on the topic of pharmacogenomic utility in pediatric psychopharmacology. He collaborates with Dr. Peter Jensen and Dr. Mark Frye in the development of a pediatric bipolar disorder biobank that will add to the understanding of this complex mood illness.